Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Xeris Pharmaceuticals, Inc.

NASDAQ: XERSHealthcare / Biotechnology / USA
9.60+0.1500+1.59%Vol 66 6791Y Perf -52.47%
Apr 18th, 2019 16:00
BID9.57 ASK9.60
Open9.38 Previous Close9.45
Pre-Market- After-Trading-
 - -%  - -%
Target Price
23.00 
Analyst Rating
— — 0.00
Potencial %
139.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)259 
Earnings Rating
Price Range Ratio 52wk %
4.82 
Earnings Date
5th Jun 2019

Today's Price Range

9.109.69

 

52wk Range

8.6727.98

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-8.57%
3 Months
-43.53%
6 Months
-51.86%
1 Year
-52.47%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
XERS9.600.15001.59
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
11.40
Current Ratio
11.60
Long Term Debt to Total Capital
0.30
Total Debt to Equity
0.42
Interest Coverage
-22.60
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
98.30
EBIT Margin
-2 334.10
EBITDA Margin
-2 329.90
Pre-tax Profit Margin
-
Profit Margin
-

Earnings HistoryEstimateReportedSurprise %
Q04 2018-1.04-0.985.77
Q03 2018-0.84-0.7115.48
Q02 2018-0.87-3.07-252.87
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date5th Jun 2019
Estimated EPS Next Report-0.83
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume66 679
Shares Outstanding (in ths.)26 937
Trades Count290
Dollar Volume512 693
Avg. Volume243 931
Avg. Weekly Volume86 723
Avg. Monthly Volume147 916
Avg. Quarterly Volume288 941

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

43%57%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News